Nature Biotechnology 24, 119 (2006)
Published online: 7 February 2006; | doi:10.1038/nbt0206-119
Amgen becomes a stronger cancer playerJim Kling
Bellingham, Washington. In a move aimed at reinforcing its presence in the oncology field, Amgen signed a deal to purchase Abgenix.
|